A Study of KH607 as Monotherpy in Adults Participants With Major Depressive Disorder

NCT07741240 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: KH607 tablets
DRUG: placebo
DRUG: KH607 tablets

Sponsor

Chengdu Kanghong Pharmaceutical Group Co., Ltd.